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Red  blood  cells  (RBCs)  fulfill  the   
essential  functions  of  transporting   
oxygen to tissues and facilitating gas   
exchange in the lungs. They are con-
tinuously produced throughout life in   
a  tightly  controlled  growth  process 
termed erythropoiesis. Erythroid dif-
ferentiation is accompanied by tempo-
rally regulated changes in cell surface 
protein expression, a reduction in cell 
size,  progressive  hemoglobinization, 
and nuclear condensation, which cul-
minates  in  extrusion  of  the  nucleus, 
RNA,  and  mitochondria  (Richmond 
et al., 2005).
Erythropoiesis  is  largely  mediated 
by a relatively small number of lineage-
restricted transcription factors, including 
GATA-1, SCL/TAL1, LMO2, LDB1, 
and KLF1 (Cantor and Orkin, 2002). 
The importance of these transcription 
factors in erythropoiesis has been dem-
onstrated unequivocally by cell-based 
ex vivo assays, as well as in knockout 
mouse models and rare patients with 
anemias. The critical transcription fac-
tors are present in diverse multiprotein   
complexes.  However,  how  distinct 
multiprotein complexes activate or re-
press transcription, and thereby regu-
late the erythroid maturation program, 
remains incompletely understood. New   
techniques, including ChIP coupled 
with  massively  parallel  sequencing 
(ChIP-seq), gene expression profiling, 
and  bioinformatic  analyses,  provide 
new information about the regulatory 
networks that coordinate erythroid cell 
maturation and function. This mini-
review will summarize recent findings 
relevant to the understanding of gene 
expression regulation in red blood cells.
GATA-1
The transcription factor GATA-1 rec-
ognizes the DNA consensus sequence 
(A/T)GATA(A/G) through two Cys-
X2-Cys-X17-Cys-X2-Cys  zinc  fingers 
that  are  characteristic  of  the  GATA 
family  (Wall  et  al.,  1988;  Evans  and 
Felsenfeld, 1989). Annotation of GATA 
consensus  sites,  even  those  that  are 
phylogenetically conserved, is a poor 
predictor of in vivo GATA-1 chromatin 
binding (Bresnick et al., 2005). Hence, 
several groups generated whole-genome 
occupancy maps for GATA-1 by using 
ChIP-seq in erythroid cell lines (Cheng 
et al., 2009; Fujiwara et al., 2009; Yu   
et al., 2009; Soler et al., 2010). Although 
three studies identified 4,000–6,000 
in vivo binding sites for GATA-1 in 
mouse erythroleukemia (MEL) cells ex-
pressing a tagged form of GATA-1 (Yu 
et al., 2009; Soler et al., 2010) or human 
K562 erythroleukemia cells (Fujiwara 
et al., 2009), a fourth study identified 
>15,000 sites occupied by GATA-1 in   
G1E-ER4 cells, which were derived from   
GATA-1 knockout mouse embryonic 
stem  cells  and  express  an  estrogen- 
inducible GATA-1 construct. Careful 
assessment of the data may help explain   
discrepancies in the number of GATA-1– 
occupied sites. These may have arisen   
from usage of different cell lines, em-
ployment of different peak calling algo-
rithms, differences in the ChIP protocols, 
or simply differences in choice of statis-
tical cut offs.
All studies demonstrated that a mi-
nority of GATA-1 binding sites (10–
15%) are located at proximal promoter 
regions close to the transcription start 
site (TSS). The bulk of GATA-1 bind-
ing (85%) occurs at distal regulatory 
elements with equal distribution be-
tween  intra-  and  intergenic  regions 
(Fujiwara et al., 2009; Yu et al., 2009). 
High-level  H3K4  monomethlyation 
(H3K4me1),  a  histone  mark  strongly 
enriched  at  functional  enhancer  re-
gions (Heintzman et al., 2007), was ob-
served at nearly all GATA-1–occupied 
DNA segments, further supporting the 
notion that GATA-1 principally binds 
enhancer regions (Cheng et al., 2009). 
To identify direct GATA-1 target genes, 
microarray gene expression profiling   
was performed (Yu et al., 2009) using 
G1E-ER4 cells (Weiss et al., 1997). G1E 
cells are arrested at the proerythroblast 
stage  of  differentiation,  but  undergo 
synchronous terminal maturation upon 
restoration of GATA-1 function (Weiss 
et al., 1997). Reexpression of GATA-1 
triggers an extensive program of gene 
activation and repression (Weiss et al., 
1997).  Superimposition  of  GATA-1 
whole-genome occupancy and gene 
expression data permitted identification   
of putative, direct GATA-1 targets. Al-
though up to 5,000 genes were found to 
be differentially expressed upon GATA-1   
activation (Cheng et al., 2009; Fujiwara   
et al., 2009; Yu et al., 2009), a sur-
prisingly  small  fraction  (300–700) 
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resulted in severe anemia and embry-
onic lethality in mice at embryonic day 
13.5. Accumulation of a SUMOylated 
form of GATA-1 was observed and   
coincided  with  down-regulation  of 
GATA-1 target genes (Yu et al., 2010b). 
for erythroid differentiation (Hung et al., 
1999; Lamonica et al., 2006). A study 
recently published in JEM revealed the 
importance of GATA-1 SUMOylation 
(Yu et al., 2010b). Genetic ablation of 
the  SUMO-specific  protease  SENP1 
of genes could be identified as direct 
GATA-1 target genes (Fujiwara et al., 
2009; Yu et al., 2009). It should also 
be noted that within those genes identi-
fied as direct GATA-1 targets, 40–57% 
were up-regulated and 41–60% were 
down-regulated  (Cheng  et  al.,  2009; 
Fujiwara et al., 2009; Yu et al., 2009),   
demonstrating that GATA-1 activates or 
represses nearly equivalent numbers of   
genes. Bioinformatic analysis of transcrip-
tion factor motifs further revealed that 
among  activated  genes,  binding  sites 
for SCL/TAL1 were highly enriched 
(Cheng  et  al.,  2009;  Fujiwara  et  al., 
2009;  Tripic  et  al.,  2009;  Yu  et  al., 
2009; Kassouf et al., 2010). Based on   
this finding, one may infer that GATA-1   
activates gene expression specifically in 
concert with SCL/TAL1 (Fig. 1). How-
ever, partners for GATA-1 in gene repres-
sion are less clear. GATA-1 is thought to 
facilitate gene repression via interaction 
with the NuRD complex; this may be 
mediated through a direct interaction be-
tween GATA-1 and FOG-1 (Hong et al.,   
2005; Rodriguez et al., 2005), as well 
as via the transcriptional repressor Gfi-1b   
in concert with the LSD1–CoREST co-
repressor complex (Fig. 1; Rodriguez   
et al., 2005; Saleque et al., 2007). Interest-
ingly, the genome-wide occupancy maps   
revealed an additional level of complexity, 
as a subset of GATA-1–repressed genes 
was also found to carry the repressive   
H3K27me3 histone mark (Cheng et al.,   
2009; Yu et al., 2009). This mark is cat-
alyzed by the polycomb repressive com-
plex 2 (PRC2), a multiprotein complex 
containing EED, Ezh1/2, and Suz12 
(Müller  et  al.,  2002;  Schuettengruber 
et al., 2007). Erythroid differentiation   
is  impaired  in  mice  with  erythroid-
specific loss of EED (Yu et al., 2009). 
Thus, the PRC2 complex participates 
in  GATA-1–mediated  gene  repres-
sion during erythroid differentiation. 
Whether GATA-1 recruits PRC2 di-
rectly, or indirectly, will be of interest 
in future studies.
It should be recognized that these 
chromatin occupancy studies do not ac-
count for posttranslational modifications 
of GATA-1. For example, GATA-1 is 
acetylated (Boyes et al., 1998), and this 
modification appears  to be important 
Figure 1.  Model of the multiprotein complexes orchestrating gene expression or repression 
in erythroid cells. Comparison of GATA-1, SCL/TAL1, and LDB1 whole-genome occupancy maps 
with gene expression profiling data suggests that the GATA-1/SCL/TAL1–LMO2–LDB1–E2A penta-
meric complex, as well as a GATA-1–independent SCL/TAL-1–containing complex, largely activate gene 
expression. GATA-1 may also activate gene expression in coordination with KLF1 (activating com-
plexes, green box). GATA-1 might repress gene expression via a multi-step process. Interaction with 
the transcriptional repressor GFI-1B recruits the LSD1/coREST complex, which results in removal of 
the activating H3K4me2 mark. To permanently silence gene expression, GATA-1 can recruit the PRC2 
complex (EED, Ezh2, and Suz12) resulting in H3K27 trimethylation and gene repression. The SCL/TAL1 
complex can recruit the corepressors ETO2 and Mtgr1 resulting in SCL/TAL1 mediated gene silencing 
(repressing complexes, red box).JEM VOL. 207, November 22, 2010 2539
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by cooccupancy of ETO2/Mtgr1 at a 
subset of SCL/TAL1 target genes (Soler 
et al., 2010), as well as de-repression of 
some  SCL/TAL1  target  genes  upon 
depletion  of  ETO2  in  erythroid  cells 
(Tripic et al., 2009). The observation 
that SCL/TAL1 and LDB1 have been 
found binding far from their closest re-
pressed  gene  prompted  Soler  et  al. 
(2010) to perform chromosome con-
formation capture sequencing (3C-seq). 
Combination of the LDB1 ChIP-seq 
and 3C-seq data revealed direct binding 
of LDB1 to DNase-hypersensitive sites 
HS2,  HS3,  and  HS4  of  the  -globin   
locus control region (LCR) and long-
range  interactions  with  the  -globin 
promoter, despite the absence of a func-
tional LDB1 binding site at the -globin 
promoter (Soler et al., 2010). It would 
be of interest to study the nature of these 
long-range interactions in the absence 
of SCL/TAL1 or LDB1.
KLF1
KLF1  (formerly  called  EKLF),  a  zinc 
finger  transcription  factor  with  three 
highly  similar  C-terminal  C2H2-type 
Kruppel zinc fingers, recognizes a sub-
set of CACC box motifs (Miller and 
Bieker, 1993). Expression of KLF1 is 
remarkably restricted to erythroid cells 
and their precursors (Miller and Bieker, 
1993). Although its essential role in eryth-
ropoiesis has been known for quite some 
time (Cantor and Orkin, 2002), few   
direct transcriptional targets have been 
identified.
Tallack  et  al.  (2010)  generated   
a  whole-genome  occupancy  map  for 
KLF1 in primary erythroid cells. In two 
independent ChIP-seq runs, KLF1 oc-
cupied between 940 and 1,400 binding 
sites  in  erythroid  cells.  16%  of  these 
binding events occurred within 1 kb of 
the TSS, whereas the majority of sites 
were  located  at  distances  of  >10  kb 
away from TSSs (Tallack et al., 2010).   
To  identify  new  direct  KLF1  target 
genes, the authors compared ChIP-seq 
data  with  gene  expression  profiles  of 
wild-type and Klf1
/ fetal liver cells 
(Hodge et al., 2006). A total of 1,099 
genes  were  differentially  expressed  in 
the absence of KLF1 in erythroid cells; 
730  genes  were  down-regulated  and 
For some time, only a handful of 
red cell–specific direct target genes of 
this complex had been identified. Two 
recent studies mapped whole-genome 
occupancy of this complex by perform-
ing  ChIP-seq  for  endogenous  SCL/
TAL1  in  primary  mouse  proerythro-
blasts (Kassouf et al., 2010) or for tagged 
LDB1  and  SCL/TAL1  in  MEL  cells 
(Soler et al., 2010). A third group gen-
erated an occupancy map of SCL/TAL1 
in G1E-ER4 cells, performing ChIP-
on-chip  analysis  using  a  tiling  array 
covering mouse chromosome 7 (Tripic 
et  al.,  2009).  Approximately  3,000–
4,000 and 5,000 genome-wide binding 
sites  were  identified  for  SCL/TAL1   
and LDB1, respectively. Approximately 
30%  of  all  SCL/TAL1  binding  sites 
were located at proximal promoter re-
gions (in this study defined as ±3 kb of 
the  TSS),  whereas  the  bulk  of  SCL/
TAL1 binding (70%) resided at distal 
regulatory elements with a distribution 
of 40 or 25% in intragenic or intergenic 
regions,  respectively  (Kassouf  et  al., 
2010). To identify putative direct SCL/
TAL1  target  genes,  microarray  gene 
expression profiling was used to com-
pare wild-type primary proerythroblasts 
with  proerythroblasts  derived  from 
mice carrying a mutation in the DNA-
binding domain of SCL/TAL1 (SCL/
TAL1
RER;  Kassouf  et  al.,  2008).  511 
differentially  expressed  genes  were 
identified, with 51% up-regulated and 
49% down-regulated. The intersection 
of  SCL/TAL1  occupancy  and  gene   
expression data resulted in an overlap   
of only 83 genes, which may be con-
sidered  direct  SCL/TAL1  targets. 
Strikingly, 75% of these genes were 
down-regulated  as  compared  with 
wild-type  cells,  indicating  that  SCL/
TAL1 largely activates gene expression. 
Analysis of motifs revealed enrichment 
of GATA binding sites close to SCL/
TAL1 binding sites at genes activated 
by SCL/TAL1, in accordance with the 
reciprocal  findings  for  GATA-1  (see 
above).  Gene  repression  mediated  by 
the SCL/TAL1 complex may be per-
formed via recruitment of the corepres-
sors ETO2 and Mtgr1 (Fig. 1; Fujiwara 
et al., 2009; Tripic et al., 2009; Soler   
et al., 2010). This conclusion is supported 
SUMOylation may modulate aspects of 
GATA-1 function beyond DNA bind-
ing, as suggested by Yu et al. (2010b), 
given  that  SUMOylation  of  FOG1   
affects its interaction with other pro-
teins (Snow et al., 2010). Further work 
is needed to interrogate protein–protein 
and  protein–DNA  interactions  of   
SUMOylated GATA-1.
In  recent  years,  microRNAs 
(miRNAs) have emerged as additional 
regulators of overall gene expression, 
representing yet another layer of con-
trol. Indeed, recent work demonstrates 
that the miR-144/451 locus is a direct 
target of GATA-1 and that mice lack-
ing  miR-144/451  or  miR-451  alone 
show impaired erythropoiesis, particu-
larly under conditions of stress (Dore   
et  al.,  2008;  Rasmussen  et  al.  2010;   
Patrick et al., 2010; Yu et al., 2010a).
SCL/TAL1–LMO2–LDB1–E2A complex
The  basic  helix–loop–helix  (bHLH) 
transcription factor SCL/TAL1 recog-
nizes  a  short  consensus  DNA  motif 
(CANNTG),  the  E-box.  SCL/TAL1 
expression  largely  parallels  that  of 
GATA-1, as it is expressed in erythroid 
cells,  megakaryocytes,  and  mast  cells 
(Cantor and Orkin, 2002). In erythroid 
cells, SCL/TAL1 forms a complex with 
the  ubiquitous  bHLH  protein  E2A, 
and also with the LIM domain con-
taining  cofactors  LMO2  and  LDB1 
(Cantor and Orkin, 2002). These pro-
teins interact with GATA-1 to form a 
pentameric complex (Fig. 1) that binds 
to  composite  E-box/GATA-1  DNA 
motifs spaced 9–11 nt apart (Wadman 
et  al.,  1997;  Cohen-Kaminsky  et  al., 
1998). LMO2, GATA-1, and SCL/TAL1 
are  all  required  for  erythropoiesis  in 
mice  (Cantor  and  Orkin,  2002),  and   
a conditional knockout mouse model 
of  SCL/TAL1  is  available  (Mikkola   
et al., 2003). In this issue, Li et al. pres-
ent the first conditional knockout of 
LDB. They find that embryos lacking 
LDB1 show defective primitive eryth-
ropoiesis and that Mx-Cre–driven de-
letion of LDB1 in adult mice results in 
a  persistent  drop  in  hematocrit  and,   
ultimately,  death,  demonstrating  that 
LDB1 is continuously required for de-
finitive erythropoiesis.2540 Networking erythropoiesis | Kerenyi and Orkin
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and GATA-1. Comparing KLF1 ChIP-
seq data with results from GATA-1 whole 
genome occupancy maps, Tallack et al. 
determined the distances between the   
nearest  GATA-1  peak  and  all  KLF1 
peaks.  Approximately  48%  of  KLF1 
peaks are located within 1 kb of GATA-1 
peaks, strongly supporting an in vivo 
cooperation of the two factors (Fig. 1). 
Finally, the authors compared GATA-1/
SCL (Cheng et al., 2009; Wilson et al., 
2009) and GATA-1/KLF1–cooccupied 
regions  and  found  minimal  overlap 
(Tallack et al., 2010). This finding was 
surprising,  given  studies  implicating 
GATA-1 in gene activation almost ex-
clusively in complex with SCL/TAL1 
(see above), but it suggests that GATA-1 
may exist in two mutually exclusive   
activating complexes (Fig. 1).
Concluding remarks
In  considering  genome-wide  occu-
pancy data, one must be cognizant of 
potential methodological pitfalls. For 
example, although the widely applied 
“nearest-neighbor approach” (Kent et al., 
2002;  Pepke  et  al.,  2009)  provides  a 
convenient way to assign transcription 
factor–binding peaks to nearby genes, it 
may oversimplify the situation, as it 
does not take into account long-range 
cis or trans interactions that frequently 
occur between promoter and enhancer 
elements. This limitation may account, 
in part, for the relatively small overlap 
between gene expression and transcrip-
tion factor occupancy data.
Nevertheless, whole genome map-
ping of transcription factor occupancy 
is  a  relatively  new  technology  that  is 
providing prodigious datasets for com-
putational and functional analyses. The 
integration of such data with profiling 
of mRNA and miRNA expression, cou-
pled with sensitive proteomics, will lead JEM VOL. 207, November 22, 2010 2541
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